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Abstract
Background: There is a need to determine the feasibility of conducting studies of chronic diseases among large cohorts of
African patients. One aim of the South African feasibility study was to determine the prevalence of chronic kidney disease
(CKD) and its association with cardiovascular disease (CVD) risk factors among school teachers.
Methods: In a cross-sectional survey of 489 teachers we captured data on demographics, CVD risk factors, anthropometry
and blood pressure. Serum glucose, creatinine, cholesterol and urine protein/creatinine ratio was measured. Glomerular fil-
tration rate was estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and the Modification of
Diet in Renal Disease study equations.
Results: Themean (6 standard deviation) age of the participants was 46.36 8.5 years, with 70.3% being female and 74.6% of
mixed ethnicity. The crude prevalence of CKD using the CKD-EPI equation was 6.1% while the age-adjusted prevalence was
6.4% (95% confidence interval 3.2–9.7%). CKDwas associated with the presence of diabetes and higher diastolic blood
pressures.
Conclusions: In our study population of relatively young, working individuals CKD was common, clinically silent and asso-
ciated with cardiovascular risk factors. The long-term complications of CKD are serious and expensive to manage and this,
therefore, constitutes an important public health problem for South Africa.
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Introduction
Chronic non-communicable diseases (CNCDs) account for
around 60% of deaths globally with 80% of these deaths occur-
ring in low- and middle-income countries (LMIC) [1]. Chronic
kidney disease (CKD) is one of these CNCDs and affects approxi-
mately 1 in 10 adults, or over 500 million people worldwide [2–
4]. The most important consequences of CKD are end-stage
renal disease (ESRD), and a greatly increased risk of cardiovas-
cular disease (CVD) and stroke [5]. Developing countries have in-
sufficient resources to deal with the CKD epidemic and its
serious long-term complications.
Given the high costs of treating ESRD, it is not surprising
that the provision of dialysis and transplantation services is
limited in LMICs and virtually non-existent in many parts of
sub-Saharan Africa [6]. However, patients with CKD are more
likely to die of CVD than to progress to ESRD as CKD is a strong
independent cardiovascular risk factor [7, 8]. Obtaining good
data on the burden of CKD is an important first step in tackling
this serious public health problem.
In Africa, research funding is heavily skewed in favour of in-
fectious diseases and limited data on CKD and ESRD can be
found. This contributes to low awareness among the public,
healthcare workers, government and other funders, and may
lead to the false perception that CKD and ESRD are not import-
ant problems in Africa.
A recent systematic review of CKD in sub-Saharan Africa [9]
reported a prevalence of 13.9%, but commented on the dearth of
studies of good quality. The Africa/Harvard School of Public
Health Partnership for Cohort Research and Training (Africa/
HSPH PaCT) is a collaboration between Harvard University and
scientists from South Africa, Uganda, Tanzania and Nigeria to
address this knowledge gap [10]. Africa/HSPH PaCT aims to in-
vestigate chronic diseases among large cohorts and provide
training opportunities for African researchers.
As part of a process to assess the feasibility of a large-scale
study of CNCDs in South Africa, and to contribute much-needed
data on the burden of CKD in African populations, our group
conducted a cross-sectional study among teachers in the
Western Cape province of South Africa to determine the preva-
lence of CKD and its association with other CVD risk factors.
Teachers were selected as the study population as we envis-
aged the larger cohort study including participants from all prov-
inces, all ethnic groups, and from urban as well as rural areas.
Teachers met these criteria and, with their relatively stable em-
ployment and high degree of literacy, were good candidates for
successful long-term follow-up. The California Teachers Study
[11] is an example of a successful cohort study involving teachers,
which has producedmultiple research publications.
The diagnosis of CKD rests on the demonstration of kidney
damage (e.g. proteinuria) or low glomerular filtration rate (GFR) for
more than 3 months. International guidelines [12] now recom-
mend that the GFR be estimated from serum creatinine concen-
trations using the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) prediction equation [13]. This equa-
tion is more accurate than the previously recommended
Modification of Diet in Renal Disease (MDRD) study equation.
Materials and methods
Study design and population
We conducted a cross-sectional survey of teachers recruited
from primary, secondary and intermediate public schools in the
Metro South Education District in Cape Town, South Africa. We
included schools employing at least 20 teachers, and excluded
teachers who were pregnant or who were likely to retire or re-
locate within the following 6 months.
Study procedures
After the permission and support of the provincial education
authorities was obtained, invitation letters explaining the pur-
pose and procedures of the study were sent to the principals of
111 schools by e-mail, letter or fax during January–March 2011.
We followed up on the invitations by e-mail and telephone. If
the principal provided permission for a school to participate,
packages of consent forms and questionnaires were delivered
to the school. Principals were requested to distribute these
packages to all their teachers. Teachers enrolled in the study by
completing the consent forms and a baseline questionnaire,
and returning these in pre-paid envelopes to the study coordin-
ation centre. Participation was entirely voluntary; those not
willing to participate were requested to provide a reason for
this.
Once a number of teachers at a particular school had re-
turned their questionnaires, a team of two to three trained
study nurses visited the school to take physical measurements
and biologic specimens (blood and urine) according to written
standard operating procedures. Teachers who had not previ-
ously responded but were willing to enrol during the nurse vis-
its were included after they completed the consent form and
questionnaire. Questionnaire and physical measurement data
from participants who gave consent for this but who were un-
willing to provide biological samples were also included in the
analyses.
Physical measurements
Weight was determined using a Seca 813 digital floor scale that
was calibrated using a weight of known mass. Measurements
were recorded to the nearest 0.1 kg with participants wearing
minimum clothing and no shoes. Height was recorded in centi-
metres to the nearest 0.1 cm using a Seca 213 stadiometer,
which was placed on a hard, flat, uncarpeted surface. Readings
were taken after removing any hair ornamentation and shoes,
after inhalation and with the reader’s eye at the level of the
head piece. Waist circumference was measured with a non-
stretchable Seca 201 tape measure placed against the skin at a
horizontal plane at the midpoint between the lowest rib and the
iliac crest at the end of a normal expiration and recorded to the
nearest 0.1 cm. The body mass index (BMI) was calculated as
weight (in kilograms) per square metre; obesity was defined as
BMI 30 kg/m2. Measurements were performed in duplicate and
the average used for analyses.
Blood pressure (BP) was measured after resting for 5min.
Readings were taken at 1 min intervals with the back supported
and the feet on the ground using an Omron 705CP-II automatic
blood pressure monitor with appropriate cuff sizes. The average
of two readings was taken to reflect the participant’s blood pres-
sure. A third reading was taken if there was a difference of
>5mmHg between the readings and the average of the second
and third readings was then taken to reflect the blood pressure.
Hypertension was defined as being on treatment for hyperten-
sion, or by a systolic BP140mmHg or diastolic BP 90mmHg,
according to the JNC 7 classification [14].
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Biological specimens
Non-fasting blood samples were taken to determine serum cre-
atinine, glucose and total cholesterol concentrations. Spot urine
samples were collected in 50-mL screw-top plastic jars for de-
termination of urine protein/creatinine ratio (UPCR). Samples
were collected in daily batches and transported on ice to be pro-
cessed by a single, internationally accredited laboratory. Serum
and urine creatinine concentrations were determined using a
kinetic colorimetric assay based on the Jaffe reaction and pro-
teinuria was quantified using an immunoturbidimetric method.
The creatinine assay was calibrated to the isotope-dilution
mass spectrometry (IDMS) reference method. Total cholesterol
was measured using an enzymatic colorimetric method and
blood glucose using an enzymatic hexokinase method. These
tests were performed on a Roche/Hitachi CobasVR c 501 system.
Estimated GFR (eGFR) was calculated using the CKD-EPI [15]
and the re-expressed four-variable MDRD equations without any
adjustment for black ethnicity. Both equations use standardized
creatinine [13]. Patients are then classified according to the
National Kidney Foundation Kidney Disease Outcomes Quality
Initiatives (NKF KDOQI) CKD classification [16]. The MDRD equa-
tion is still the most widely used, but it systematically underesti-
mates GFR at higher values. The CKD-EPI equation was developed
as a response to this limitation [13] and is now recommended as
the preferred GFR prediction equation [15]. We report GFR based
on both of these commonly used equations as neither has yet
been validated in our local population. We defined CKD as pro-
teinuria 0.30mg/mg or a GFR <60 mL/min/1.73 m2, or self-
reported structural abnormalities of the kidneys. Diabetes was
defined as a random blood glucose 11.1mmol/L or a history of
diabetes or the use of anti-diabetic medications. Dyslipidaemia
was defined as a total cholesterol >5.2mmol/L or high density
lipoprotein (HDL) cholesterol <1.0mmol/L in males and<1.3m-
mol/L in females. Metabolic syndrome was defined as three or
more of the following according to the Revised National
Cholesterol Education Programme-Adult Treatment Panel III (R-
ATPIII) definition: waist circumference >102cm in males or
>88cm in females, systolic BP 130mmHg or diastolic BP
85mmHg, or being on treatment for previously diagnosed
hypertension, presence of diabetes and presence of
dyslipidaemia.
Participants received feedback on their blood pressure and
laboratory results by personalized SMS or e-mail, according to
their stated preference, and were advised to see their usual
physicians for readings outside the normal range.
Statistical analysis
Data were analysed with the assistance of the Centre for
Statistical Consultation at Stellenbosch University. Continuous
variables are reported as means 6 standard deviations, or me-
dians and interquartile ranges (IQR), whereas categorical data
are reported as numbers and percentages. The crude CKD
prevalence was age-adjusted using the distribution of the adult
age categories (20 years and older, in 10-year intervals) of the
WHO World Standard Population [17]. Exploratory analysis to
examine the association between potential risk factors and the
presence of CKD was performed using the t-test and the
Wilcoxon rank sum test, where data were not normally distrib-
uted. Logistic regression was used to calculate odds ratios (ORs).
For categorical variables, the chi-squared test was used and
Fisher’s exact test when the numbers were small. Baptista–Pike
mid-p confidence intervals (CIs) were calculated for the ORs of
the categorical variables. The significant variables as well as
those expected to be associated with CKD were then entered
into a logistic regression model. Statistical analyses were done
using Stata 13 (StataCorp 2013) with the significance level set at
0.05.
Ethics
Ethics approval was obtained from the Health Research Ethics
Committee of Stellenbosch University (project number: N10/05/
111 school principals invited to parcipate
59 gave wrien permission to approach their teachers
36 declined
16 no response
1779 document packs delivered to schools
1243 not returned
43 responded but declined
4 non-educators excluded
489 teachers enrolled in the study
Fig. 1. Study flow diagram.
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Following three rounds of invitation, permission was obtained
from 59 principals of the 111 schools approached (53.2%). A total
of 1779 document packs were distributed and 489 teachers were
enrolled into the study (Figure 1). An additional 43 teachers re-
sponded that they were unwilling to participate, indicating that
they were either too busy, not interested or that the information
being requested was of too personal a nature. There were 17
included participants who completed a questionnaire but did
not provide blood or urine samples.
Demographic characteristics of participants
As shown in Table 1, 70.3% of the participants were female and
74.6% were of mixed ethnicity. The mean age was 46.36 8.5
years.
Clinical and laboratory data
The mean BMI was in the obese range at 31.667.0 kg/m2, with
mean waist circumference 98.1 6 12.9 cm and 95.06 14.4 cm
for males and females, respectively. Mean systolic BP was
134.2618.4mmHg and diastolic BP 79.46 10.8mmHg. The
mean blood glucose, total serum cholesterol and HDL choles-
terol levels were 5.6 6 2.0mmol/L, 5.4 6 1.1mmol/L and 1.4 6
0.4mmol/L, respectively. All the participants who provided in-
formation on their HIV status (n ¼ 340) indicated that they were
HIV-negative.
Mean serum creatinine was 90 6 14 lmol/L for males and
67612 lmol/L for females, with the mean eGFR by the CKD-EPI
equation being 88615 mL/min/1.73 m2 and 94 6 16 mL/min/
1.73 m2, respectively (P < 0.001). Using the MDRD equation, the
mean eGFR was 81 6 15 mL/min/1.73 m2 and 85 6 17 mL/min/
1.73 m2, respectively (P ¼ 0.017). White participants had lower
mean eGFR values compared with participants from other eth-
nic groups (76 6 17 mL/min/1.73 m2 and 84 6 16 mL/min/1.73
m2, respectively, P ¼ 0.003). Lower eGFR was also associated
with increasing age (P < 0.001). The presence of hypertension
was associated with lower GFR on univariate analysis (P ¼
0.038), but there was no significant association on multivariate
analysis where the model included age, gender and ethnicity.
Median UPCR was 0.07mg/mg (IQR 0.05–0.10mg/mg). On
multiple linear regression, protein excretion assessed by UPCR
as a continuous variable was increased in female participants
(P < 0.032), those with higher blood glucose concentrations
(P < 0.001) and higher systolic BPs (P ¼ 0.019), and those with a
personal (P < 0.001) or family history (P ¼ 0.025) of kidney
disease.
Prevalence of CKD
Participants were considered to have CKD if they had a low
eGFR by the CKD-EPI equation, or proteinuria. An additional
participant, who reported having had a previous nephrectomy,
was also classified as having CKD. The overall crude prevalence
of CKD was 6.1% (29 of 472 participants). Only two of these par-
ticipants reported a previous history of kidney disease. When
the MDRD equation was used to estimate GFR, the crude preva-
lence was 10.0% (47 of 472 participants). The age-adjusted
prevalence of CKD was 6.4% (95% CI 3.2–9.7%).
The prevalence of low eGFR<60 mL/min/1.73 m2 was 1.8%
(8/452 participants) by the CKD-EPI equation and 6.0% (27/452)
using the MDRD equation. Significant proteinuria
(UPCR0.30mg/mg) was found in 4.5% (21/470) of participants;
one participant with proteinuria had a low eGFR by the CKD-EPI
equation and two had a low eGFR by the MDRD equation. No
participant had an eGFR below 30 mL/min/1.73 m2.
Association of CKD with CVD risk factors
The association of CKD with potential risk factors is
summarized in Table 2. On this univariate analysis, CKD
was significantly associated with the presence of diabetes
(P¼ 0.030), abdominal obesity (P ¼ 0.046) and higher diastolic
BPs (P¼ 0.032).
On multiple logistic regression analysis, diabetes and higher
diastolic BPs were significantly associated with the presence of
CKD (Table 3).
Discussion
The crude prevalence of CKD in our study population was 6.1%,
with an age-adjusted prevalence of 6.4%. Low eGFR and protein-
uria were present in 1.8% and 4.5% of participants, respectively.
This is a substantial burden of disease in a relatively young,
working population. Our participants also had a very high
prevalence of other CVD risk factors. CKD was associated with
the presence of diabetes, abdominal obesity and higher diastolic
BP. The association of CKD with CVD risk factors is in line with
reports from other population-based studies [18, 19].
There have been few population-based CKD prevalence
studies from Africa, with most published research focused on
the screening of high risk populations or hospital-based pa-
tients. Sumaili et al. [18] reported an overall CKD prevalence of
12.4% in the city of Kinshasa, Democratic Republic of Congo,
Table 1. Baseline characteristics of study participants
Characteristic n Value
Demographics









Measures of renal function and CKD
Serum creatinine (mmol/L) 455 74 6 17
eGFR-CKD-EPI (mL/min/1.73 m2) 452 92 6 16
eGFR-MDRD (mL/min/1.73 m2) 452 84 6 17
UPCR (mg/mg) 470 0.07 (0.05–0.10)
Low eGFR-CKD-EPI 452 8 (1.8)
Low eGFR-MDRD 452 27 (6.0)
Proteinuria 0.30mg/mg 470 21 (4.5)
CKD (eGFR by CKD-EPI) 472 29 (6.1)
CKD (eGFR by MDRD) 472 47 (10.0)
Data expressed as mean 6 standard deviation, median (IQR) or as number (per-
centage). CKD is defined by the presence of a UPCR0.30mg/mg or a low eGFR
of<60mL/min/1.73 m2 or self-reported structural abnormalities of the kidneys.
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with the prevalence of proteinuria (5%) being similar to that in
our study. A study by Eastwood et al. from the Ashanti region of
Ghana [20] compared different methods of estimating renal
function. The MDRD equation yielded a CKD prevalence (based
on eGFR <60 mL/min/1.73 m2; proteinuria was not assessed) of
1.6%, and 7.4% if omitting the correction factor for black ethni-
city. The CKD-EPI equation yielded a prevalence of 1.7%, and
4.7% without correction for black ethnicity. Benghanem Gharbi
et al. [21] have just published their report on the MAREMAR
study, a CKD screening and prevention programme in Morocco.
The study is especially noteworthy for the large number of par-
ticipants, the use of random sampling and the demonstration of
the chronicity of proteinuria, haematuria and low GFR for the
diagnosis of CKD. They reported an overall CKD prevalence of
5.1% and highlighted the problem of under-diagnosing CKD in
young people with GFR above the threshold of 60 mL/min/1.73
m2 but below the third percentile for age and sex. The article
also points out the over-diagnosis of CKD in older people who
have GFR values just below the threshold but no other evidence
of kidney damage.
The South African study by Matsha et al. [19] determined the
prevalence of CKD in a mixed-ethnicity community in the city of
Cape Town. They found a CKD prevalence of 23.9% by the MDRD
equation and 17.3% by the CKD-EPI equation. These surprisingly
high prevalence estimates are among the highest reported in un-
selected populations in Africa. Their cohort was community
based, with a very high burden of hypertension, diabetes, obesity
and smoking. In comparison, the participants in our study were
younger, working individuals with a lower prevalence of diabetes
(9.3 versus 26.4%) and smoking (18.7 versus 40.5%), and with a
mean age which was lower by 6.6 years.
In the systematic review of Zhang et al. [4], the CKD preva-
lence increased with age, gender and ethnicity. It also varied
strongly with the eGFR equation used. Most studies used the
MDRD equation, and these reported lower prevalences than
studies using the Cockcroft-Gault formula.
The diagnosis and effective treatment of the early stages of
CKD is especially important in Africa and other low-resource
environments because the options for treating the late compli-
cations such as ESRD are very limited or non-existent. This is in
contrast to higher-income countries where dialysis or trans-
plantation is available to most patients who require these ex-
pensive therapies. Screening programmes aimed at individuals
at higher risk of developing CKD (those with diabetes,
Table 2. Comparison of potential risk factors between participants with and without CKD
Characteristic CKD No CKD P OR (95% CI)
Age (years) 47.3 6 9.1 46.4 6 8.4 0.677 1.01 (0.97–1.06)
Male 7 (24.1) 133 (30.0) 0.501 1.35 (0.58–3.42)
Ethnicity
Black 4 (14.3) 68 (16.3) 1.000 1.17 (0.42–3.20)
Mixed ethnicity 21 (75) 311 (74.4) 0.944 1.03 (0.43–2.66)
Indian/Asian 0 (0) 7 (1.7) 1.000 0.00 (0.00–8.67)
White 3 (10.7) 32 (7.7) 0.474 1.45 (0.44–4.58)
Diabetic 6 (20.7) 38 (8.6) 0.030 2.78 (1.10–6.87)
Hypertensive 16 (55.2) 210 (47.6) 0.430 1.35 (0.64–2.77)
Current smoker 2 (7.7) 79 (19.2) 0.194 0.35 (0.08–1.33)
History of kidney disease 2 (9.5) 7 (2.4) 0.113 4.36 (0.86–22.53)
History of high cholesterol 8 (36.4) 87 (29.4) 0.491 1.37 (0.58–3.40)
History of CVD/stroke 4 (15.4) 29 (8.1) 0.262 2.08 (0.73–5.88)
Family history of kidney disease 3 (10.3) 34 (8.5) 0.728 1.25 (0.38–3.90)
Family history of diabetes 13 (46.4) 210 (52.8) 0.516 0.78 (0.37–1.71)
Family history of CVD/stroke 15 (51.7) 224 (54.8) 0.728 0.89 (0.41–1.95)
Family history of hypertension 19 (67.9) 261 (63.0) 0.609 1.24 (0.56–2.89)
Abdominal obesity 23 (79.3) 268 (60.8) 0.046 2.48 (1.01–5.87)
BMI 34.0 6 8.4 31.5 6 6.9 0.213 1.04 (1.00–1.09)
Diastolic BP 83 6 11 79 6 11 0.032 1.03 (1.00–1.07)
Systolic BP 141 6 24 134 6 18 0.117 1.02 (1.00–1.04)
Total cholesterol 5.5 6 1.1 5.4 6 1.1 0.697 1.13 (0.78–1.63)
HDL 1.5 6 0.4 1.4 6 0.4 0.452 1.39 (0.53–3.61)
Low HDL 7 (27.0) 130 (30.3) 0.715 0.85 (0.33–2.08)
Metabolic syndrome 4 (15.4) 80 (18.7) 0.800 0.79 (0.29–2.24)
Unadjusted (univariate) analysis. Data expressed as mean 6 standard deviation or as number (percentage). There were 29 participants with CKD and 443 without CKD.
Those with CKD were more likely to have diabetes, abdominal obesity and higher diastolic BPs. CKD was defined by the presence of UPCR0.30mg/mg or low eGFR
of<60mL/min/1.73 m2. Abdominal obesity was defined by a waist circumference102 cm for men and88 cm for women. Low HDL was defined as<1.0mmol/L in
males and<1.3mmol/L in females. Metabolic syndrome was defined according to the R-ATPIII definition.
Table 3. Multiple logistic regression analysis of risk factors associ-
ated with CKD
Characteristic OR (95% CI) P
Age (years) 0.97 (0.93–1.03) 0.447
Male 2.21 (0.74–11.91) 0.169
White ethnicity 2.96 (0.74–11.91) 0.127
Diabetic 10.09 (1.61–63.20) 0.014
Current smoker 0.46 (0.10–2.12) 0.321
DBP (mmHg) 1.05 (1.01–1.10) 0.011
Metabolic syndrome 0.17 (0.03–1.17) 0.073
Adjusted (multivariate) analysis. There was an independent association of CKD
with diabetes and higher diastolic BPs. CKD was defined by the presence of
UPCR 0.30mg/mg or low eGFR of<60mL/min/1.73 m2. Metabolic syndrome
was defined according to the R-ATPIII definition.
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hypertension, HIV, people over 50 years of age, etc.) are, there-
fore, essential.
Clearly, the choice of method to assess GFR is critical and
can have a major impact on the classification of an individual
as having CKD or not, on the stage of CKD and on the reported
population prevalence. The commonly used prediction equa-
tions need to be validated in local populations against gold
standard methods. Two African studies, both from South Africa,
have compared prediction equations with GFR measured by nu-
clear medicine methods. Van Deventer et al. [22] reported better
performance of the MDRD equation in South Africans of African
origin when the correction factor for black ethnicity was not
used. Madala et al. [23] also concluded that the MDRD equation
should be used without the correction factor, and suggested
that a new correction factor, or a new equation, is needed for
South Africans of Indian origin.
Recent international guidelines [15], and also those of the
South African Renal Society [24], now recommend the use of the
CKD-EPI equation for estimating GFR. The CKD-EPI equation is
more accurate and less biased at higher (near-normal) GFR val-
ues [13]. It results in a lower prevalence estimate of CKD and
more accurate risk prediction for adverse outcomes compared
with the MDRD equation [25]. We support the use of the CKD-
EPI equation for population studies where most participants
would be expected to have normal or near-normal GFR.
However, as neither the CKD-EPI nor the MDRD equation has
been validated in our mixed-ethnicity population, we have re-
ported the results for both equations.
While current guidelines use a universal GFR threshold of 60
mL/min/1.73 m2 for the diagnosis of CKD, this may not be ap-
propriate in all cases. Pottel et al. [26] have suggested that a cut-
off of 75 mL/min/1.73 m2 be used for children and young adults
as they may have low GFR values, below the third percentile for
age and sex, but still above 60 mL/min/1.73 m2. At the other end
of the age spectrum, there have been calls for caution in label-
ling older patients as having CKD if they have mild, stable re-
ductions in GFR (between 45 and 60 mL/min/1.73 m2) without
any other evidence of kidney damage or systemic disease [27].
Our study has several limitations. The recruitment was chal-
lenging, and the sample size is relatively small. Schools from
the Metro South Education District of Cape Town were invited
to participate and the teachers from these schools may not be
representative of all teachers in the province or in the country.
After agreeing to their schools’ participation, principals distrib-
uted document packages with informed consent and question-
naires to their teachers. The exact number of teachers invited,
and hence the true response rate, could therefore not be ascer-
tained. We have no data on the characteristics of those teachers
who declined to participate and cannot say whether they dif-
fered in important ways from our participants.
Another limitation concerns the diagnosis of CKD, which re-
quires the presence of abnormal kidney structure or function
for>3 months [15]. In common with many cross-sectional epi-
demiologic studies like the NHANES [28] and other studies, our
study did not include repeat estimates of GFR or protein excre-
tion. In the absence of an acute illness likely to cause acute kid-
ney injury, people with abnormal kidney function or damage
may be inferred to have CKD, although repeat ascertainment is
recommended for accurate diagnosis [15] and will often result
in lower estimates for CKD prevalence [21]. Creatinine was
measured using an assay based on the Jaffe reaction, which is
more susceptible to interferences than the enzymatic method.
The assay was, however, calibrated to the IDMS reference
method. While the CKD-EPI equation is recommended for
estimating GFR, any prediction equation should ideally be vali-
dated against gold standard methods and that still needs to be
done in our local population.
For logistic reasons, fasting blood samples could not be ob-
tained, which may have led to misclassification of diabetes and
dyslipidaemia. Our study cohort consisted mainly of female
participants, reflecting the gender distribution in the teaching
profession. In the Western Cape province, 70.5% of teachers are
female while country-wide the proportion is 69.4% [29]. In terms
of ethnicity, they were not representative of the national popu-
lation (79.2% Black African and 8.9% individuals of mixed eth-
nicity), but more closely approximated the ethnic distribution of
the population of the Western Cape province (48.8% mixed eth-
nicity, 32.8% Black, 15.7% White) [30]. The only other population
study of CKD in South Africa [19] involved a cohort comprising
only individuals of mixed ancestry. The role of the healthy
worker effect in the cohort studied may be significant, and
would lead to under-estimation of the true CKD prevalence.
Regarding the planning of future studies, there are two
issues that should be highlighted. First, it would be important to
establish which GFR prediction equation would be most appro-
priate for the diagnosis and staging of CKD in our setting. A
study comparing GFR estimated by the MDRD and CKD-EPI
equations with GFR measured from the plasma clearance of
99mTc-DTPA is currently under way at our institution. Most of
the participants in this study will be of mixed ethnicity. It would
also be very useful to have the data from the studies by Van
Deventer et al. [22] and Madala et al. [23] re-analysed to include
the CKD-EPI equation. A second issue is related to our recruit-
ment methods. These need to be reconsidered if many partici-
pants have to be recruited rapidly for a large cohort study. We
found that school principals acted as gatekeepers and that we
recruited the most participants from schools where the princi-
pals themselves were enrolled. Further pilot studies would be
necessary to find the most efficient recruitment strategy. We
will need to explore ways of getting more support from school
principals and also explore ways of approaching and enrolling
teachers directly, perhaps with the help of the provincial educa-
tion department and the teacher trade unions.
In conclusion, CKD is a common and often under-diagnosed
condition. The prevalence found in this relatively young co-
hort—which likely underestimates the population prevalence—
suggests that it represents a serious public health problem in
South Africa in view of the serious long-term complications and
their associated costs. Early detection and management of CKD
with the aim of retarding progression and reducing the inci-
dence of both ESRD and CVD mortality is required. The diagno-
sis of CKD requires reliable estimates of GFR; it is therefore
essential to conduct studies in our local populations, which val-
idate the commonly used prediction equations against gold
standard methods.
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